Richard Whetzel Schill
Adult Health · Lake Mary, FLNPI 1154612257
Payments from drug & device makers
Across 840 payments — averaging $27.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$3K
- Insulet Corporation$3K
- Novo Nordisk$2K
- Lilly USA, LLC$2K
- Boehringer Ingelheim$1K
- Xeris Pharmaceuticals, Inc.$1K
- plus $11K from 49 others
What the payments were for
- Food & beverage$23,06399%
- Education$800%
- Gifts$590%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$23,202 in reported general payments places this provider in the 95th percentile of 2,237 adult health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 284 | $460,677 |
| MounjaroTirzepatide | 164 | $235,965 |
| TrulicityDulaglutide | 155 | $225,408 |
| JardianceEmpagliflozin | 142 | $174,502 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 123 | $142,946 |
| RybelsusSemaglutide | 65 | $124,962 |
| FarxigaDapagliflozin Propanediol | 135 | $121,548 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 82 | $107,469 |
| FiaspInsulin Aspart (Niacinamide) | 48 | $94,273 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 78 | $91,401 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 70 | $86,754 |
| Tresiba Flextouch U-200Insulin Degludec | 78 | $81,854 |
| KerendiaFinerenone | 61 | $71,493 |
| Tresiba Flextouch U-100Insulin Degludec | 54 | $61,827 |
| Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt | 45 | $57,819 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus, Fiasp, Novolog | $2,492 | $706,575448 claims |
| Lilly USA, LLCMounjaro, Trulicity, Lyumjev, Humalog | $1,578 | $511,755366 claims |
| Boehringer IngelheimJardiance, Synjardy Xr, Glyxambi, Tradjenta | $1,401 | $298,472246 claims |
| AstraZenecaFarxiga | $533 | $121,548135 claims |
| BayerKerendia | $1,066 | $71,49361 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $852 | $51,27546 claims |
| MerckJanuvia, Steglatro | $109 | $17,41823 claims |
| Amneal Pharmaceuticals LLCUnithroid, Levothyroxine Sodium | $489 | $15,828372 claims |
| AbbVieSynthroid | $207 | $12,570120 claims |
| Cequr CorporationCequr Simplicity | $706 | $8,10511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,237 adult health providers in Florida.
Other adult health in Lake Mary
- Patricia PagnottaMaitland$441K
- Carly KoelschSarasota$265K
- Norma SolisMiami$150K
- Ashley PontenbergWinter Park$136K
- Jeffrey HernandezMiami$122K
- Jamie JohnsonTampa$58K
- Jessica MangesClearwater$52K
- Sita SwamyOrlando$49K
- Alejandro Dela CruzOrlando$44K
- Cynthia OteroMaitland$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.